Objectives: Mirikizumab demonstrated significant efficacy compared to placebo in patients with Crohn's disease (CD) in the phase 3 VIVID-1 study. Here, we report the impact of mirikizumab versus placebo on health-related quality of life (HRQoL) and work productivity in VIVID-1.
Methods: VIVID-1 patients randomized to receive mirikizumab (N=579) or placebo (N=199) were included.
Background: Large studies have shown that stroke is among the most relevant causes of acquired adult disability. Walking and balance impairment in stroke survivors often contribute to a restriction in daily activities and social participation. Task-oriented training (TOT) is an effective treatment strategy and manual therapy (MT) is used successfully to enhance ankle joint flexibility in this population.
View Article and Find Full Text PDFTo evaluate a business-centered assignment implemented in a pharmacy elective course at two different institutions and analyze student perceptions of the delivery platforms used and the value and utility of the assignment. The ambulatory care electives at Butler University and Samford University introduce students to the expanding role of the ambulatory care pharmacist, emphasizing business plan development for new ambulatory care pharmacy services. As part of the elective, students are asked to work in groups to complete a business plan for a new ambulatory care service of their choosing.
View Article and Find Full Text PDF